Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine
Helena Chaytow, Kiterie M. E. Faller, Yu-Ting Huang, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100346-100346
Open Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

Pushing the boundaries: future directions in the management of spinal muscular atrophy
Fiona Moultrie, Laura Chiverton, Isabel Hatami, et al.
Trends in Molecular Medicine (2025)
Open Access
Spinal Muscular Atrophy (SMA): Treatment strategies, challenges and future prospects
Nikunja Kishor Mishra, Amiyakanta Mishra
Deleted Journal (2025), pp. 100031-100031
Closed Access
FRET‐Based Sensor Zebrafish Reveal Muscle Cells Do Not Undergo Apoptosis in Starvation or Natural Aging‐Induced Muscle Atrophy
Jia Hao, Renfei Wu, Hongmei Yang, et al.
Advanced Science (2025)
Open Access
Skeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy
Andrew I. Mikhail, Sean Y. Ng, Donald Xhuti, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy
Amber Hassan, Raffaella di Vito, Tommaso Nuzzo, et al.
Neurobiology of Disease (2025), pp. 106849-106849
Open Access
International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease
Katherine B. Howell, Susan M. White, Amy McTague, et al.
npj Genomic Medicine (2025) Vol. 10, Iss. 1
Open Access
Glial Cells in Spinal Muscular Atrophy: Speculations on Non-Cell-Autonomous Mechanisms and Therapeutic Implications
Andrej Belančić, Tamara Janković, Elvira Meni Maria Gkrinia, et al.
Neurology International (2025) Vol. 17, Iss. 3, pp. 41-41
Open Access
Patient-reported assessment of bulbar function in spinal muscular atrophy (SMA): Validation of a self-report scale
Maureen A. Lefton‐Greif, Lisa Belter, Jill Jarecki, et al.
Journal of Neuromuscular Diseases (2025)
Closed Access
Global Economic Burden of Spinal Muscular Atrophy: A Systematic Literature Review
Rawda Elshahawy, Baher Elezbawy, Rasha Ashmawy, et al.
Cureus (2025)
Open Access
Hiding in Plain Sight: Polymorphs of Riluzole
Abdel Rahman Al Ahmad, Thierry Maris, James D. Wuest
Crystal Growth & Design (2025)
Closed Access
Network pharmacology approach to unravel the neuroprotective potential of natural products: a narrative review
Pankaj Kumar Singh, Maheshkumar R. Borkar, Gaurav Doshi
Molecular Diversity (2025)
Closed Access
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy
Francesco Errico, Carmen Marino, Manuela Grimaldi, et al.
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1431-1431
Open Access | Times Cited: 15
A roadmap to precision treatments for familial pulmonary fibrosis
Killian Hurley, Mari Ozaki, Quentin Philippot, et al.
EBioMedicine (2024) Vol. 104, pp. 105135-105135
Open Access | Times Cited: 3
JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam
Claudia A. Chiriboga, Claudio Bruno, Tina Duong, et al.
Journal of Neurology (2024) Vol. 271, Iss. 8, pp. 4871-4884
Open Access | Times Cited: 3
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges
Umme Sabrina Haque, Toshifumi Yokota
(2024)
Open Access | Times Cited: 3
Virtual Screening, Polymorphism, and Formation Thermodynamics Study of Riluzole Multicomponent Crystals with Dihydroxybenzoic Acids
Alexander P. Voronin, Anna G. Ramazanova, Andrei V. Churakov, et al.
Crystal Growth & Design (2024)
Closed Access | Times Cited: 3
Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy
Emma R Sutton, Ariane Beauvais, Rebecca Yaworski, et al.
EBioMedicine (2024) Vol. 110, pp. 105444-105444
Open Access | Times Cited: 3
Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial
Silvia Bonanno, Riccardo Giossi, Riccardo Zanin, et al.
Journal of Neurology (2022) Vol. 269, Iss. 11, pp. 5858-5867
Open Access | Times Cited: 12
Gene transfer therapy in children with spinal muscular atrophy: A single‐center experience with a cohort of 25 children
Nidheesh Chencheri, Gail Alexander, Ahmed Nugud, et al.
Muscle & Nerve (2023) Vol. 68, Iss. 3, pp. 269-277
Closed Access | Times Cited: 7
Real-world evidence: Risdiplam in a patient with spinal muscular atrophy type I with a novel splicing mutation and one SMN2 copy
Kai Ma, Kaihui Zhang, Defang Chen, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 13, pp. 1120-1130
Open Access | Times Cited: 2
Newborn screening in Mexico and Latin America: present and future
Claudia Gonzaga‐Jauregui, Rodrigo Moreno‐Salgado, Jacqueline Tovar-Casas, et al.
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy
Cassie Ables, Catalina Jaramillo, E. Lynne Wood, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101296-101296
Closed Access | Times Cited: 2
One-Year Pilot Study Results of Newborn Screening for Spinal Muscular Atrophy in the Republic of Croatia
Darija Šimić, Ana Šarić, Ana Škaričić, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 50-50
Open Access | Times Cited: 2
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy.
Amber Hassan, Raffaella di Vito, Tommaso Nuzzo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Scroll to top